See more : D-Market Elektronik Hizmetler ve Ticaret A.S. (HEPS) Income Statement Analysis – Financial Results
Complete financial analysis of EC Healthcare (2138.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of EC Healthcare, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Intuit Inc. (ITU.DE) Income Statement Analysis – Financial Results
- Innovative Food Holdings, Inc. (IVFH) Income Statement Analysis – Financial Results
- China Grand Automotive Services Group Co., Ltd. (600297.SS) Income Statement Analysis – Financial Results
- Japan Insulation Co., Ltd. (5368.T) Income Statement Analysis – Financial Results
- Sherborne Investors (Guernsey) B Limited (SIGB.L) Income Statement Analysis – Financial Results
EC Healthcare (2138.HK)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.echealthcare.com
About EC Healthcare
EC Healthcare, an investment holding company, engages in the provision of medical and healthcare services in Hong Kong, Macau, and the People's Republic of China. The company operates through three segments: Medical, Aesthetic Medical and Beauty and Wellness, and Others. It provides quasi-medical, beauty and wellness, medical imaging, medical surgery, aesthetic medical beauty, aesthetic medical, dental, hair treatment, vaccine, chiropractic, psychological, and orthopedics services. It also offers administrative, management, laboratory testing, performance marketing, marketing, and travel agency services; sells beauty and skincare products; operates in healthcare machines and property investment holding businesses; and provides multi-channel networking and related services, and veterinary services. The company offers products and services primarily under private-label brands, such as PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH. The company was formerly known as Union Medical Healthcare Limited and changed its name to EC Healthcare in April 2021. EC Healthcare was founded in 2005 and is headquartered in Mong Kok, Hong Kong.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.21B | 3.88B | 2.92B | 2.08B | 1.95B | 1.85B | 1.32B | 974.90M | 707.92M | 621.35M | 489.90M | 234.71M |
| Cost of Revenue | 3.51B | 3.20B | 2.17B | 1.56B | 1.30B | 880.96M | 615.06M | 485.83M | 315.82M | 260.62M | 247.07M | 171.20M |
| Gross Profit | 704.74M | 674.67M | 753.05M | 519.47M | 649.93M | 971.50M | 707.08M | 489.08M | 392.10M | 360.73M | 242.83M | 63.51M |
| Gross Profit Ratio | 16.74% | 17.41% | 25.79% | 24.97% | 33.36% | 52.44% | 53.48% | 50.17% | 55.39% | 58.06% | 49.57% | 27.06% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 219.15M | 232.37M | 161.43M | 116.00M | 186.26M | 222.30M | 157.82M | 118.54M | 75.77M | 67.96M | 83.56M | 46.90M |
| Selling & Marketing | 207.22M | 172.72M | 139.38M | 109.38M | 124.44M | 154.54M | 126.93M | 68.46M | 38.02M | 23.93M | 23.81M | 28.43M |
| SG&A | 426.37M | 548.66M | 422.00M | 332.56M | 310.70M | 376.84M | 300.52M | 187.00M | 123.18M | 111.46M | 107.36M | 75.34M |
| Other Expenses | 0.00 | -40.07M | -40.97M | -35.89M | 3.62M | -128.12M | -89.94M | 9.98M | -46.55M | -39.49M | 0.00 | 0.00 |
| Operating Expenses | 597.45M | 548.66M | 422.00M | 332.56M | 307.08M | 535.70M | 389.18M | 248.98M | 209.18M | 152.39M | 147.81M | 95.42M |
| Cost & Expenses | 4.10B | 3.75B | 2.59B | 1.89B | 1.61B | 1.42B | 1.00B | 734.81M | 525.00M | 413.01M | 394.88M | 266.62M |
| Interest Income | 15.57M | 4.53M | 1.36M | 1.70M | 1.09M | 14.29M | 12.26M | 4.51M | 1.49M | 2.25M | 1.65M | 710.26K |
| Interest Expense | 100.84M | 71.67M | 52.81M | 26.42M | 18.06M | 2.74M | 43.23M | 29.72M | 23.00M | 889.68K | 0.00 | 0.00 |
| Depreciation & Amortization | 625.55M | 586.74M | 432.37M | 309.86M | 245.78M | 61.75M | 37.62M | 29.17M | 24.64M | 18.15M | 15.71M | 9.76M |
| EBITDA | 737.83M | 782.27M | 807.25M | 597.19M | 624.25M | 501.13M | 340.21M | 260.06M | 242.96M | 230.20M | 107.04M | -7.85M |
| EBITDA Ratio | 17.52% | 18.39% | 26.15% | 23.88% | 30.21% | 27.05% | 25.73% | 26.68% | 34.32% | 37.05% | 21.85% | -10.47% |
| Operating Income | 186.03M | 126.01M | 331.05M | 186.91M | 342.85M | 439.38M | 302.59M | 230.89M | 218.32M | 212.05M | 91.33M | -34.32M |
| Operating Income Ratio | 4.42% | 3.25% | 11.34% | 8.98% | 17.60% | 23.72% | 22.89% | 23.68% | 30.84% | 34.13% | 18.64% | -14.62% |
| Total Other Income/Expenses | -169.16M | 10.18M | -8.97M | -232.94M | -122.43M | 10.70M | 27.56M | -14.41M | -54.95M | -17.50M | -38.80M | 3.12M |
| Income Before Tax | 16.87M | 123.86M | 322.08M | 260.91M | 360.40M | 450.08M | 330.15M | 244.61M | 184.41M | 210.60M | 96.67M | -31.20M |
| Income Before Tax Ratio | 0.40% | 3.20% | 11.03% | 12.54% | 18.50% | 24.30% | 24.97% | 25.09% | 26.05% | 33.89% | 19.73% | -13.29% |
| Income Tax Expense | 1.18M | 29.16M | 50.91M | 40.30M | 50.25M | 65.58M | 52.02M | 41.11M | 35.10M | 35.82M | 15.26M | 2.03M |
| Net Income | -18.95M | 69.65M | 197.50M | 192.87M | 286.58M | 361.11M | 279.22M | 200.70M | 148.66M | 174.42M | 81.12M | -32.30M |
| Net Income Ratio | -0.45% | 1.80% | 6.76% | 9.27% | 14.71% | 19.49% | 21.12% | 20.59% | 21.00% | 28.07% | 16.56% | -13.76% |
| EPS | -0.02 | 0.06 | 0.17 | 0.19 | 0.29 | 0.37 | 0.28 | 0.21 | 0.20 | 0.24 | 0.11 | -0.04 |
| EPS Diluted | -0.02 | 0.06 | 0.17 | 0.19 | 0.29 | 0.37 | 0.28 | 0.21 | 0.20 | 0.24 | 0.11 | -0.04 |
| Weighted Avg Shares Out | 1.19B | 1.18B | 1.15B | 1.03B | 985.09M | 983.88M | 981.26M | 964.77M | 749.10M | 735.00M | 735.00M | 735.02M |
| Weighted Avg Shares Out (Dil) | 1.19B | 1.18B | 1.17B | 1.03B | 988.38M | 986.64M | 981.26M | 964.77M | 749.10M | 735.00M | 735.00M | 735.00M |
Source: https://incomestatements.info
Category: Stock Reports